e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Pleural and lower respiratory tract infections and bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Diagnostic importance of quantitative evaluation of plasma CRP in COPD
G. Ilonidis, G. Anogianakis, I. Giavazis, E. Theofilogiannakos, P. Glouftsios, A. Anogeianaki (Thessaloniki, Greece)
Source:
Annual Congress 2004 - Pleural and lower respiratory tract infections and bronchiectasis
Session:
Pleural and lower respiratory tract infections and bronchiectasis
Session type:
Thematic Poster Session
Number:
3889
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Ilonidis, G. Anogianakis, I. Giavazis, E. Theofilogiannakos, P. Glouftsios, A. Anogeianaki (Thessaloniki, Greece). Diagnostic importance of quantitative evaluation of plasma CRP in COPD. Eur Respir J 2004; 24: Suppl. 48, 3889
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Utility of procalcitonin, neopterin, C-reactive protein and MR-proANP measurement in the management of exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005
Role of biomarkers in the assessment and phenotyping asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Diagnostic utility of diaphragm ultrasound for discriminating severity in COPD patients
Source: International Congress 2019 – Thoracic ultrasound in clinical practice
Year: 2019
Electrophoresis of blood serum: A helpful diagnostic tool for identifying respiratory patients with alpha1-antitrypsin deficiency
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Human chitotriosidase analysis: a reliable biomarker of sarcoidosis severity
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
Comparison of two clinical probability scores combined with C-reactive protein and D-dimer in the diagnosis of pulmonary embolism
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
The serum YKL-40 is a useful biomarker for asthma
Source: International Congress 2017 – Techniques to treat asthma
Year: 2017
Serum procalcitonin level: clinical significance
Source: Eur Respir J 2011; 37: 723
Year: 2011
Association of serum bilirubin and clinical outcomes in COPD
Source: International Congress 2019 – Comorbidities in COPD and asthma: body composition and diabetes
Year: 2019
Circulating total leptin as a diagnostic and prognostic biomarker in sepsis
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap
Source: Annual Congress 2013 –Is it really asthma?
Year: 2013
Clinical significance of serum MRGPRX2 as a new biomarker in allergic asthma
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Association of serum pneumoproteins with clinical course of COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept